Study for efficacy of usage of enteral nutrient with immuno-balance modulation action in perioperative management of pediatric patients

Study for efficacy of usage of enteral nutrient with immuno-balance modulation action in perioperative management of pediatric patients - Efficacy in usage of enteral nutrient with immuno-balance modulation action

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024993

Enrollment

Registered

2016-12-15

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirschsprung&#39

Interventions

In the control group, the following enteral nutrient will be administered (breast milk or artificial milk for infants, Racol for infants). Dose and duration: Before surgery, the patient will take en

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hirschsprung's disease, Ano-rectal malformation, Congenital biliary dilatation, GERD

Exclusion criteria

Exclusion criteria: Patients whose enteral nutrition is impossible

Design outcomes

Primary

Measure	Time frame
Change of postoperative inflammatory condition	—

Secondary

Measure	Time frame
the nutritional status and fecal condition after surgery, the incidence of infectious complications, the number of hospital days	—

Countries

Japan

Contacts

Public ContactKouji Masumoto

University of Tsukuba Hospital Department of Pediatric Surgery, Faculty of Medicine

kmasu@md.tsukuba.ac.jp029-853-3094

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026